GlassScriptPhysician profile
Dhanpat C Mohnot
NPI 1780689364
$25,751.09
in general payments reported to CMS, 2019-2025
47 companies · $3,263 in 2025
The $3,263 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,615 · 2020: $6,878 · 2021: $2,184 · 2022: $1,791 · 2023: $1,926 · 2024: $3,095 · 2025: $3,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,245 · Education: $38.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,245.29 |
| Education | $38.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $5,601.71 | 2019-2022 | |
| Promius Pharma LLC | $5,084.63 | 2019 | |
| Abbvie INC. | $3,219.99 | 2021-2025 | |
| Ucb, INC. | $1,682.25 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Eisai INC. | $1,533.55 | 2019-2025 | |
| Amgen INC. | $890.91 | 2019-2025 | Uplizna |
| Lundbeck LLC | $775.26 | 2019-2025 | Vyepti, Rexulti |
| Teva Pharmaceuticals USA, INC. | $712.27 | 2019-2025 | Ajovy |
| Sunovion Pharmaceuticals INC. | $659.88 | 2019-2022 | |
| Pfizer INC. | $640.97 | 2023-2025 | |
| Sk Life Science, INC. | $624.40 | 2020-2023 | |
| Lilly USA, LLC | $570.17 | 2019-2025 | Emgality, Kisunla, Reyvow |
| Supernus Pharmaceuticals, INC. | $489.23 | 2019-2024 | Qelbree |
| Argenx US, INC. | $481.02 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Jazz Pharmaceuticals INC. | $417.69 | 2022-2025 | Epidiolex |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dhanpat Mohnot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.